Last reviewed · How we verify

NCT04184154: Gyn&Co

Sexual Quality of Life of Patients With Gynecologic Cancer Treated With Brachytherapy.

Completed Last updated 4 November 2021
What this trial tests

trial testing Questionnaires in Pelvic Cancer in 167 participants. Completed in 8 November 2017.

Timeline
5 April 2017
Primary endpoint
15 July 2017
8 November 2017

Quick facts

Lead sponsorInstitut du Cancer de Montpellier - Val d'Aurelle
StatusCompleted
Study typeOBSERVATIONAL
Enrollment167
Start date5 April 2017
Primary completion15 July 2017
Estimated completion8 November 2017
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle — full company profile →

Who can join

18 and older, female only, with Pelvic Cancer or Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gynecologic cancer treatments (chemoradiotherapy, brachytherapy and surgery) greatly impact patients' sexual quality of life (QoL). Use of the vaginal dilators may reduce vaginal stenosis. Since 2011, our "Gyn and Co LR" patient education program aims to optimize early care of sexual disorders following treatment of cervical and endometrial cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Pelvic Cancer

Currently open trials in the same condition.

Other Institut du Cancer de Montpellier - Val d'Aurelle trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04184154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing